Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
16.46
-0.17 (-1.02%)
At close: Feb 21, 2025, 4:00 PM
16.57
+0.11 (0.67%)
After-hours: Feb 21, 2025, 4:00 PM EST
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $503.46 million as of February 21, 2025. Its market cap has decreased by -33.87% in one year.
Market Cap
503.46M
Enterprise Value
-301.90M
1-Year Change
-33.87%
Ranking
Category
Stock Price
$16.46
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $503.46M, an increase of 221.70%. That is a compound annual growth rate of 14.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 503.50M | -10.87% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |